
Monday, December 12, 2022 6:05:13 PM
Buy and Sell stocks at your own risk. What I say in my posts are strictly my opinion.

Liked By
Spread the love. Be the first to like this post!
Recent TNXP News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/30/2023 11:13:37 AM
- Tonix Pharmaceuticals Presents Positive Efficacy and Safety Data from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 5th International Congress on Controversies in Fibromyalgia • GlobeNewswire Inc. • 03/30/2023 11:00:00 AM
- Annual Report to Security Holders (ars) • Edgar (US Regulatory) • 03/29/2023 10:08:14 AM
- Tonix Pharmaceuticals Announces Oral Presentations at the World Vaccine Congress • GlobeNewswire Inc. • 03/27/2023 11:00:00 AM
- Tonix Pharmaceuticals Presents Non-Clinical Data on TNX-2900 for the Potential Treatment of Hyperphagia in Adolescents and Young Adults with Prader-Willi Syndrome at the Rare Disease Innovation and Partnership Summit • GlobeNewswire Inc. • 03/23/2023 08:15:00 PM
- Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia • GlobeNewswire Inc. • 03/23/2023 11:00:00 AM
- Tonix Pharmaceuticals to Present at the 2023 Virtual March Investor Summit • GlobeNewswire Inc. • 03/22/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/20/2023 09:09:22 PM
- Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit • GlobeNewswire Inc. • 03/16/2023 08:05:00 PM
- Tonix Pharmaceuticals Initiates Enrollment in Phase 2 ‘UPLIFT’ Study of TNX-601 ER (Tianeptine Hemioxalate Extended-Release Tablets) for the Treatment of Major Depressive Disorder (MDD) • GlobeNewswire Inc. • 03/16/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 09:29:55 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 11:07:01 AM
- Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights • GlobeNewswire Inc. • 03/13/2023 11:00:00 AM
- Tonix Pharmaceuticals Announces Results from a Preclinical Study of Murine TNX-1700 Presented in a Poster at the Keystone Symposia, “Cancer Immunotherapy: Mechanisms of Response Versus Resistance” • GlobeNewswire Inc. • 03/07/2023 12:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/27/2023 12:03:12 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:39:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:39:08 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:38:13 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/24/2023 11:35:15 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/23/2023 09:23:39 PM
- Tonix Pharmaceuticals Announces New Board Member, R. Newcomb Stillwell • GlobeNewswire Inc. • 02/23/2023 09:15:00 PM
- Tonix Pharmaceuticals Describes Emerging Research on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients During Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?” • GlobeNewswire Inc. • 02/22/2023 12:00:00 PM
- Tonix Pharmaceuticals to Participate in Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?” • GlobeNewswire Inc. • 02/16/2023 12:00:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/14/2023 09:02:00 PM
- New to The Street Announces its Line-up, Four Interviews on Episode #438, Airing on the Fox Business Network, Tonight, Monday, February 13, 2023, 10:30 PM PT • GlobeNewswire Inc. • 02/13/2023 02:30:00 PM
FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM
ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM
Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM
ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM
Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM
OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM